Rokeya Akter
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Medicinal Plants and Bioactive Compounds 7
- RNA Interference and Gene Delivery 4
- Pharmacology 10
- Cholinesterase and Neurodegenerative Diseases 7
- Co-authors
- Md. Habibur Rahman (22 shared papers)Tanima Bhattacharya (11 shared papers)Deepak Kaushik (8 shared papers)Chenmala Karthika (12 shared papers)Priti Tagde (7 shared papers)Hitesh Chopra (4 shared papers)Mohamed M. Abdel‐Daim (4 shared papers)Vineet Mittal (5 shared papers)
- Journals
- Molecules (6 papers)Environmental Science and Pollution Research (5 papers)CNS & Neurological Disorders - Drug Targets (4 papers)Current Pharmaceutical Design (3 papers)Life (2 papers)
- Partner nations
- BangladeshIndiaSouth Korea
In The Last Decade
Rokeya Akter
42 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 149
- Molecular Medicine 195
- Geriatrics and Gerontology 75
- Health Informatics 24
- Biological Psychiatry 39
- Complementary and alternative medicine 115
Countries citing papers authored by Rokeya Akter
This map shows the geographic impact of Rokeya Akter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rokeya Akter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rokeya Akter more than expected).
Fields of papers citing papers by Rokeya Akter
This network shows the impact of papers produced by Rokeya Akter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rokeya Akter. The network helps show where Rokeya Akter may publish in the future.
Co-authors
The 25 scholars most cited alongside Rokeya Akter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 168 | |
| 2 | 2020 | 142 | |
| 3 | 2021 | 134 | |
| 4 | 2021 | 133 | |
| 5 | 2021 | 109 | |
| 6 | 2022 | 90 | |
| 7 | 2021 | 58 | |
| 8 | 2021 | 48 | |
| 9 | 2021 | 45 | |
| 10 | 2021 | 45 | |
| 11 | 2021 | 38 | |
| 12 | 2021 | 38 | |
| 13 | 2021 | 32 | |
| 14 | 2021 | 31 | |
| 15 | 2022 | 30 | |
| 16 | 2021 | 29 | |
| 17 | 2021 | 29 | |
| 18 | 2022 | 24 | |
| 19 | 2020 | 22 | |
| 20 | 2021 | 21 |
About Rokeya Akter
Rokeya Akter is a scholar working on Molecular Biology, Pharmacology, Physiology, Molecular Medicine and Oncology, having authored 43 papers that have together received 1.5k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (7 papers), Medicinal Plants and Bioactive Compounds (7 papers), RNA Interference and Gene Delivery (4 papers), Curcumin's Biomedical Applications (4 papers), COVID-19 Clinical Research Studies (3 papers), Natural Antidiabetic Agents Studies (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Molecular Medicine (195 citations), Geriatrics and Gerontology (75 citations), Health Informatics (24 citations), Biological Psychiatry (39 citations) and Complementary and alternative medicine (115 citations). Rokeya Akter has collaborated with scholars based in Bangladesh, India and South Korea. Frequent co-authors include Md. Habibur Rahman, Tanima Bhattacharya, Deepak Kaushik, Chenmala Karthika, Priti Tagde, Hitesh Chopra, Mohamed M. Abdel‐Daim, Vineet Mittal, Md. Tanvir Kabir and Tapan Behl. Their work appears in journals such as Molecules, Environmental Science and Pollution Research, CNS & Neurological Disorders - Drug Targets, Current Pharmaceutical Design and Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.